Skip to main content
. 2015 Jul 22;89(19):9932–9938. doi: 10.1128/JVI.01337-15

FIG 3.

FIG 3

In vitro dose-response curves of six filovirus entry inhibitors on infectious EBOV and MARV. Six filovirus entry inhibitors were evaluated in Vero E6 cells against infectious eGFP Ebola virus (eGFP-EBOV) or MARV/Angola infection at 8 2-fold serial dilution concentrations ranging from 0.78 μM to 100 μM. The IC50s were calculated by four-parameter dose-response curve-fitting in GraphPad. Results are from three replicates.